Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.44 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.44 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | FYN | P06241 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ABL1 | P00519 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29421891 | 0.86 | EPHX2 (0.57) | MAPTCYP3A4EPHX2ACHECA9 | |
| SCHEMBL4472439 | 0.86 | EPHX2 (0.57) | MAPTCYP3A4EPHX2ACHECA9 | |
| SCHEMBL12587650 | 0.84 | MAPT (0.52) | MAPTCYP3A4EPHX2ACHEPTGS1 | |
| SCHEMBL1808984 | 0.82 | EPHX2 (0.49) | MAPTCYP3A4EPHX2ACHEPTGS2 | |
| SCHEMBL684134 | 0.82 | MAPT (0.48) | MAPTCYP3A4EPHX2ACHEPTGS1 | |
| SCHEMBL70823 | 0.81 | MAPT (0.58) | MAPTCYP3A4ACHEPTGS2GRIN2D | |
| SCHEMBL5770364 | 0.81 | MAPT (0.48) | MAPTCYP3A4EPHX2ACHEPTGS1 | |
| SCHEMBL27497325 | 0.80 | MAPT (0.64) | MAPTCYP3A4EPHX2ACHEPTGS1 | |
| SCHEMBL24407972 | 0.79 | CYP3A4 (0.47) | MAPTCYP3A4EPHX2ACHEPTGS1 | |
| SCHEMBL30542065 | 0.79 | TDP1 (0.52) | MAPTCYP3A4EPHX2ALOX5KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250276107-A1 | HYDROGEL SYSTEMS AND METHODS FOR TREATING FISTULA AND OTHER INDICATIONS | TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION (US) | 2025-09-04 | — | — | US | claimed |
| CN-109276563-B | Application of pharmaceutical composition in preparing medicine for treating or preventing individual infection virus | 珠海市鑫展生物科技有限公司 | 2021-04-09 | — | — | CN | claimed |
| US-3930862-A | DYE DEVELOPER TRANSFER PHOTOSENSITIVE MATERIAL WITH SUBSTITUTED CATECHOL AUXILIARY DEVELOPER | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-06 | — | — | US | claimed |
| US-20250276107-A1 | HYDROGEL SYSTEMS AND METHODS FOR TREATING FISTULA AND OTHER INDICATIONS | TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION (US) | 2025-09-04 | — | — | US | disclosed |
| CN-109276563-B | Application of pharmaceutical composition in preparing medicine for treating or preventing individual infection virus | 珠海市鑫展生物科技有限公司 | 2021-04-09 | — | — | CN | disclosed |
| CN-109276563-A | Application of pharmaceutical composition in preparing medicine for treating or preventing individual infection virus | 珠海市鑫展生物科技有限公司 | 2019-01-29 | — | — | CN | disclosed |
| US-20090137687-A1 | Compositions and Methods With Enhanced Therapeutic Activity | OXIGENE, INC. (US) | 2009-05-28 | — | — | US | disclosed |
| US-3930862-A | DYE DEVELOPER TRANSFER PHOTOSENSITIVE MATERIAL WITH SUBSTITUTED CATECHOL AUXILIARY DEVELOPER | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137687-A1 | Compositions and Methods With Enhanced Therapeutic Activity | NQO1, MKI67, COMT | MAPT 4096/4885CYP3A4 561/4885EPHX2 231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.